Predictions
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€16.01
07.10.12
07.10.12
€12.50
28.11.12
28.11.12
27.10%
28.11.12
28.11.12
Ariad Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.38
06.10.12
06.10.12
€25.00
02.01.13
02.01.13
-21.80%
02.01.13
02.01.13
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€26.85
06.10.12
06.10.12
€31.50
18.02.13
18.02.13
17.39%
18.02.13
18.02.13
Rennova Health Inc.
Start price
Target price
Perf. (%)
€14,458,500
06.10.12
06.10.12
€10,350,000
01.11.12
01.11.12
0.00%
01.11.12
01.11.12
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€16.52
05.10.12
05.10.12
€12.00
21.11.12
21.11.12
15.29%
21.11.12
21.11.12
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
EXCO Resources Inc.
Start price
Target price
Perf. (%)
€94.34
03.10.12
03.10.12
€120.00
03.04.13
03.04.13
-16.73%
03.04.13
03.04.13
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€16.99
30.09.12
30.09.12
€24.00
24.10.12
24.10.12
8.11%
24.10.12
24.10.12
Viavi Solutions Inc
Start price
Target price
Perf. (%)
€9.58
29.09.12
29.09.12
€13.00
09.10.12
09.10.12
-13.02%
09.10.12
09.10.12
Apple Inc.
Start price
Target price
Perf. (%)
€18.39
29.09.12
29.09.12
€19.64
09.10.12
09.10.12
-5.87%
09.10.12
09.10.12
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High valuation
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€7.01
27.09.12
27.09.12
€12.60
10.10.12
10.10.12
-52.35%
10.10.12
10.10.12
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€16.17
25.09.12
25.09.12
€10.50
25.03.13
25.03.13
23.29%
25.03.13
25.03.13